Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Antibiotics, history

Although streptomycin was not the first antibiotic (penicillin, a fungal product, had been isolated some years earlier), its discovery was a landmark in antibiotic history. It was the first effective therapeutic for tuberculosis, a disease that had terrorized humans for cenmries and a cause of human morbidity and mortality unmatched by wars or any other pestilence. Streptomycin was the first aminoglycoside to be identified and characterized and is noteworthy in being the first useful antibiotic isolated from a bacterial source. At the present time, the use... [Pg.1]

R. B. Sykes and D. P. Bonner, "Monobactam Antibiotics History and Development," in J. D. Williams and P. Woods, Eds., Aztreonam, The Antibiotic Discovery for Gram-negative Infections, Royal Society Medicine International Congress Symposium Series No. 89, Royal Society Medicine, London, 1985, pp. 3-24. [Pg.897]

The level of antibiotic resistance of the gut flora of pigs has been found to be influenced by factors other than the inclusion of antibiotics in the diet " " such factors include the herd environment, history and the opportunity for cross-contamination. [Pg.105]

Now that we have provided you with an overview of the history of penicillin production, we will examine some more details of the biotransformation of -lactams. We will briefly outline the normal biosynthesis pathways that lead to their production and then consider how these products may be diversified in vitro to give a wider range of valuable compounds. We begin by briefly explaining how the fi-lactam antibiotics are effective as therapeutic agents. [Pg.164]

In this chapter, by using the examples of -lactams we have briefly examined how microbial cultures may be used to produce sufficient antibiotics to meet market demands. We have also explained how enzymes (or cells) may be used to biotransform, and thereby diversify, antibiotics. By outlining the history of penicillin production, we explained how analysis and manipulation of culture regimes may be used to enhance the yields of antibiotics (and other secondary products). These studies led to die concept of directed biosynthesis by precursor feeding. [Pg.181]

It is important to obtain details regarding isotretinoin (Accutane, Roacutane) treatment and history of keloid or hypertrophic scar formation. Isotretinoin use necessitates a delay period of 6-12 months (depending on the skin thickness and oiliness) until chemical peel is performed. Active acne is not a contraindication for chemical peel. In these cases the peel is combined with systemic antibiotics for 2-3 weeks. It is always advisable to consider isotretinoin treatment after the peel to avoid acne flare and scar reappearance. [Pg.93]

Before the peel prophylactic acyclovir, vala-cyclovir or famvir is given to patients with history of recurrent herpes simplex. Systemic antibiotics (minocycline) are important for patients with active acne. [Pg.93]

Review culture and sensitivity history over the last 1 to 2 years. What antibiotics were used in the past, and did the patient appear to respond better to a particular regimen ... [Pg.255]

Review the pharmacokinetic history. Are there any possible changes in clearance since the last antibiotic course Will the patient be discharged home on IV antibiotics Can the IV regimen be simplified or made more convenient for home administration Recommend appropriate doses based on the patient s clearance and an appropriate but convenient schedule. [Pg.255]

Eradication therapy with a proton pump inhibitor-based three-drug regimen should be considered for all patients who test positive for HP and have an active ulcer or a documented history of either an ulcer or ulcer-related complication. Different antibiotics should be used if a second course of HP eradication therapy is required. [Pg.269]

Long -term antibiotic prophylaxis for SBP decreases mortality in patients with a history of SBP and low-protein ascites [ascitic fluid albumin less than 1 g/dL (less than 10 g/L)]. [Pg.323]

Consider antibiotic prophylaxis for SBP in patients with a history of variceal bleeding or prior SBP. [Pg.335]

A 73-year-old man with a history of diabetes mellitus, chronic kidney disease, gout, osteoarthritis, and hypertension is hospitalized with possible urosepsis. He recently completed a 10-day course of antibiotics and was ready for discharge when his morning labs showed an increase in BUN and serum creatinine concentration. Upon examination, he was found to have 2+ pitting edema, weight gain, nausea, elevated blood pressure, and rales on chest auscultation. [Pg.363]

Treatment Exit-site infections may be treated immediately with empiric coverage, or treatment may be delayed until cultures return. Empiric treatment of catheter-related infections should cover S. aureus. Coverage for P. aeruginosa should also be included if the patient has a history of infections with this organism.49 Cultures and sensitivity testing are particularly important in tailoring antibiotic therapy for catheter-related infections to ensure eradication of the organism and prevent recurrence or related peritonitis. [Pg.399]

Broad intravenous antibiotic coverage for the encapsulated organisms can include ceftriaxone or cefotaxime. For patients with true cephalosporin allergy, clindamycin may be used. If staphylococcal infection is suspected owing to previous history or the patient appears acutely ill, vancomycin should be initiated. Macrolide antibiotics, such as erythromycin and azithromycin, may be initiated if Mycoplasma pneumonia is suspected. While the patient is receiving broad-spectrum antibiotics, their regular use of penicillin for prophylaxis can be suspended. Fever should be controlled with acetaminophen or ibuprofen. Because of the risk of dehydration during infection with fever, increased fluid may be needed.6,27... [Pg.1014]

Empirical therapy should be directed at the most likely pathogen (s) for a specific patient, taking into account age, risk factors for infection (including underlying disease and immune dysfunction, vaccine history, and recent exposures), CSF Gram stain results, CSF antibiotic penetration, and local antimicrobial resistance patterns. [Pg.1033]

Oral, narrow-spectrum antibiotic therapy with activity against Staphylococcus aureus and streptococcal species. Include coverage for MRSA (HA- or CA-MRSA) according to patient history and resistance patterns in the area. [Pg.1083]

A 62-year-old male with history of diabetes and PVD comes to the emergency department complaining of a "painful sore" on his left lower leg. After questioning him, you determine that the wound has been present for months and has not responded to oral antibiotic therapy. On physical examination, a large, deep wound with purulent drainage is seen. [Pg.1180]

AD is a 60-year-old woman with a history of poorly controlled diabetes mellitus and MSSA nasal colonization. She weighs 54 kg and is 156 cm tall. She presents today for a hysterectomy. She has no allergies to any medications. The surgeon approaches you for recommendations on prophylactic antibiotic use. [Pg.1236]

C. difficile history of antibiotic use, advanced age, underlying illness 5-10 days of antibacteria treatment (range 1st day to 10 weeks of antibiotics) mild to severe inflammatory diarrhea toxins A and B monoglucosylation of Rho protein - disruption of actin cytoskeleton —> mucosal disruption. - COX-2 - prostaglandin E2 —> synthesis of inflammatory cytokines... [Pg.25]

In patients, who experienced a clinical exacerbation of UC and who had a past history of serious adverse reactions to steroids, the antibiotic (400 mg b.i.d. for 4 weeks) was added to mesalazine (2.4 g daily) treatment [49]. In 7 out of 10 patients (i.e. 70%) a clinical remission was achieved without corticoid use, thus showing that rifaximin displays a steroid-sparing effect. [Pg.100]

Porta E, Germano A, Ferrieri A, Koch M The natural history of diverticular disease of the colon A role for antibiotics in preventing complications A retrospective study. Eur Rev Med Pharmacol Sci 1994 16 33-39. [Pg.114]

A 39-year-old male with aortic insufficiency and a history of no drug allergies is given an intravenous dose of antibiotic as a prophylaxis preceding the insertion of a valve prosthesis. As the antibiotic is being infused, the patient becomes flushed over most of his body. What antibiotic was given ... [Pg.62]


See other pages where Antibiotics, history is mentioned: [Pg.338]    [Pg.338]    [Pg.473]    [Pg.403]    [Pg.152]    [Pg.41]    [Pg.152]    [Pg.87]    [Pg.66]    [Pg.188]    [Pg.824]    [Pg.824]    [Pg.1038]    [Pg.1044]    [Pg.1083]    [Pg.1095]    [Pg.1095]    [Pg.1123]    [Pg.1134]    [Pg.1236]    [Pg.66]    [Pg.164]    [Pg.31]    [Pg.85]    [Pg.219]   
See also in sourсe #XX -- [ Pg.10 , Pg.11 , Pg.12 , Pg.13 , Pg.14 , Pg.15 , Pg.16 , Pg.17 , Pg.18 ]




SEARCH



© 2024 chempedia.info